Effectiveness and safety of sacral neuromodulation for neurogenic bladder

References

• Bavani AG, Hanafi MG, Sarkarian M. An investigation into the sensitivity of shear wave ultrasound elastography to measure the anterior bladder wall pressure in patients with neurogenic bladder. J Family Med Prim Care. 2019;8(4):1342–1346.
   PubMedGoogle Scholar
• Przydacz M, Denys P, Corcos J. What do we know about neurogenic bladder prevalence and management in developing countries and emerging regions of the world? Ann Phys Rehabil Med. 2017;60(5):341–346. DOI:10.1016/j.rehab.2017.02.008 Epub 2017 Jun 13
   PubMed Web of Science ®Google Scholar
• Persu C, Braschi E, Lavelle J. A review of prospective Clinical Trials for neurogenic bladder: pharmaceuticals. Cent European J Urol. 2014;673:264–269. 10.5173/ceju.2014.03.art11 Epub 2014 Aug 18
   PubMedGoogle Scholar
• Wu SY, Chang SJ, Yang SS, et al. Botulinum toxin injection for medically refractory neurogenic bladder in children: a systematic review. Toxins (Basel). 2021;13(7):447.
   PubMed Web of Science ®Google Scholar
• Ghroubi S, Chmak J, Borgi O, et al. Translation and validation of the Intermittent Catheterisation Difficulty Questionnaire (ICDQ) in an Arabic population. Arab J Urol. 2019;181:22–26. 10.1080/2090598X.2019.1694762 eCollection 2020
   PubMed Web of Science ®Google Scholar
• Chan YY, Sandlin SK, Kurzrock EA, et al. The current use of stem cells in bladder tissue regeneration and bioengineering. Biomedicines. 2017;5(1):4.
   PubMed Web of Science ®Google Scholar
• Rabadi MH, Aston C. Complications and urologic risks of neurogenic bladder in veterans with traumatic spinal cord injury.Spinal Cord. 2014;53(3):200–203. DOI:10.1038/sc.2014.205 Epub 2014 Nov 18
   PubMed Web of Science ®Google Scholar
• Liberman D, Ehlert MJ, Siegel SW. Sacral neuromodulation in urological practice. Urology. 2017;99:14–22. DOI:10.1016/j.urology.2016.06.004 Epub 2016 Jun
   PubMed Web of Science ®Google Scholar
• Steele SS. Sacral nerve stimulation: 50 years in the making. Can Urol Assoc J. 2012;6(4):231–232.
   PubMed Web of Science ®Google Scholar
• Jaggi A, Fatoye F. Real world treatment patterns in the neurogenic bladder population: a systematic literature review. Transl Androl Urol. 2017;6(6):1175–1183.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med. 2009;151(4):264–269. DOI:10.7326/0003-4819-151-4-200908180-00135
   Google Scholar
• Howick J, Chalmers I, Glasziou P, et al. The 2011 Oxford CEBM levels of evidence (introductory document). Oxford Centre for Evidence-BasedMedicine. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
   Google Scholar
• Andretta E, Simeone C, Ostardo E, et al. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. J Neurolog Sci. 2014;347(1–2):257–261. DOI:10.1016/j.jns.2014.10.010 Epub 2014 Oct 12
   PubMed Web of Science ®Google Scholar
• Chaabane W, Guillotreau J, Castel-Lacanal E, et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn. 2011;30(4):547–550. DOI:10.1002/nau.21009
   PubMed Web of Science ®Google Scholar
• Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, et al. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164(5):1476–1480.
   PubMed Web of Science ®Google Scholar
• Engeler DS, Meyer D, Abt D, et al. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol. 2015;15(1):105.
   PubMed Web of Science ®Google Scholar
• Guys JM, Haddad M, Planche D, et al. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172(4 Part 2):1673–1676.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Del Popolo G. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord. 2009;47(6):486–491. DOI:10.1038/sc.2008.172 Epub 2009 Feb 24
   PubMed Web of Science ®Google Scholar
• Lombardi G, Musco S, Celso M, et al. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord. 2014;52(3):241–245. DOI:10.1038/sc.2013.155 Epub 2014 Jan 7
   PubMed Web of Science ®Google Scholar
• Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21(2):223–228. DOI:10.1007/s00192-009-1023-6 Epub 2009 Oct 30
   PubMed Web of Science ®Google Scholar
• Minardi D, Muzzonigro G. Lower urinary tract and bowel disorders and multiple sclerosis: role of sacral neuromodulation: a preliminary report. Neuromodulation. 2005;8(3):176–181.
   PubMed Web of Science ®Google Scholar
• Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol. 2012;30(1):123–128. DOI:10.1007/s00345-011-0669-0 Epub 2011 Mar 15
   PubMed Web of Science ®Google Scholar
• Wöllner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord. 2015;54(2):137–140. DOI:10.1038/sc.2015.124 Epub 2015 Jul 28
   PubMed Web of Science ®Google Scholar
• Amarenco G, Sheikh Ismaël S, Chesnel C, et al. Diagnosis and clinical evaluation of neurogenic bladder. Eur J Phys Rehabil Med. 2017;53(6):975–980.
   PubMed Web of Science ®Google Scholar
• Nseyo U, Santiago-Lastra Y. Long-term complications of the neurogenic bladder. Urol Clin North Am. 2017;44(3):355–366.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Y. Expert consensus on diagnosis and treatment of neurogenic bladder after strok. Chinese J Stroke. 2016;11:1057–1066.
   Google Scholar
• Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol. 2008;23(5):717–725.
   PubMed Web of Science ®Google Scholar
• Softness KA, Thaker H, Theva D, et al. Onabotulinumtoxin a (Botox): a reasonable alternative for refractory neurogenic bladder dysfunction in children and young adults. Neurourol Urodyn. 2021;40(8):1981–1988.
   PubMed Web of Science ®Google Scholar
• Jezernik S, Craggs M, Grill WM, et al. Electrical stimulation for the treatment of bladder dysfunction: current status and future possibilities. Neurological res. 2002;24(5):413–430.
   PubMed Web of Science ®Google Scholar
• Kilgore KL, Anderson KD, Peckham PH. Neuroprosthesis for individuals with spinal cord injury. Neurological res. 2020;1–13. DOI:10.1080/01616412.2020.1798106
   Web of Science ®Google Scholar
• Szymański JK, Słabuszewska-Jóźwiak A, Zaręba K, et al. Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review. Wideochir Inne Tech Maloinwazyjne. 2019;144:476–485. 10.5114/wiitm.2019.85352 Epub 2019 May 23
   PubMedGoogle Scholar
• Amend B, Khalil M, Kessler TM, et al. How does sacral modulation work best? Placement and programming techniques to maximize efficacy. Curr Urol Rep. 2011;12(5):327–335.
   PubMedGoogle Scholar
• De Groat WC, Ryall RW. Reflexes to sacral parasympathetic neurones concerned with micturition in the cat. Journal of Physiology. 1969;200(1):87–108.
   PubMed Web of Science ®Google Scholar
• van der Pal F, Heesakkers JP, Bemelmans BL. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol. 2006;16(4):261–267.
   PubMed Web of Science ®Google Scholar
• Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989;142(2 Part 1):340–345.
   PubMed Web of Science ®Google Scholar
• Zhang SH, Chen Y. Research progress of sacral nerve stimulationWorld. Chin J Dig Dis. 2020;28(24):1266–1271.
   Google Scholar
• Widmann B, Galata C, Warschkow R, et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study. J Neurogastroenterol Motil. 2019;25(1):159–170.
   PubMed Web of Science ®Google Scholar
• La Rosa VL, Platania A, Ciebiera M, et al. A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being. Prz Menopauzalny. 2019;18(2):89–93. DOI:10.5114/pm.2019.86834 Epub 2019 Jun 28.
   PubMedGoogle Scholar
• Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Rev Med Devices. 19(2):161–187. 2022 Jan 21. 10.1080/17434440.2022.2032655 Online ahead of print
   PubMed Web of Science ®Google Scholar
• Redshaw JD, Lenherr SM, Elliott SP, et al. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury. BMC Urol. 2018;18(1):72. DOI:10.1186/s12894-018-0383-y Published 2018 Aug 29.
   PubMed Web of Science ®Google Scholar
• De Wachter S, Knowles CH, Elterman DS, et al. New technologies and applications in sacral neuromodulation: an update. Adv Ther. 2020 Feb;37(2):637–643. DOI:10.1007/s12325-019-01205-z.
   PubMed Web of Science ®Google Scholar
• Erol B, Danacioglu YO, Peters KM. Current advances in neuromodulation techniques in urology practices: a review of literature. Turk J Urol. 2021;47(5):375–385.
   PubMed Web of Science ®Google Scholar